Skip to main content
II

Instapath Inc.

Instapath develops patented fluorescence microscopy imaging systems for rapidly digitizing fresh pathology tissue samples without cutting or fixing. Their devices enable immediate, non-destructive compositional analysis of tissue directly at the point of procedure. The company also offers a remote slide scanning service utilizing their Luci technology for large specimen imaging.

Houston, United StatesFounded 20176700+ followers
Updated 20 months ago

Funding

$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

NS
Funding rounds are not available yet.

Founders

Product

Problem

Traditional pathology workflows involve time-consuming tissue processing, sectioning, and staining, delaying diagnosis and potentially compromising sample integrity. This can lead to increased procedure times, repeat biopsies, and tissue loss, impacting patient care and hospital efficiency.

Solution

Instapath offers digital imaging solutions that rapidly convert tissue samples into high-resolution digital images using patented fluorescence microscopy. This technology enables immediate evaluation at the point of procedure, eliminating the need for traditional processing steps like cutting and fixing. The platform preserves tissue integrity, ensuring downstream analytical testing is not affected. Instapath's solutions aim to reduce the need for repeat biopsies, minimize tissue loss, and accelerate diagnostic workflows, ultimately improving patient outcomes and increasing hospital revenue.

Target Audience

The primary target audience includes pathologists, physicians, researchers, and healthcare representatives in hospitals and clinical settings who require rapid and accurate tissue analysis.

Features

  • Neo: A Class I medical device for immediate determination of tissue composition using fluorescence microscopy.
  • Luci: A system for imaging large pathology specimens without laborious processing or destruction, compatible with fresh, fixed, or frozen samples.
  • LuciNow: An on-demand, remote slide scanning service providing access to Luci's features through a customized service model.
  • Patented fluorescence microscopy technology for rapid tissue imaging.
  • Digital images generated within minutes, enabling immediate evaluation.
  • Zero cutting, zero fixing, and zero tissue loss during the imaging process.
  • Preserves tissue integrity for downstream analytical testing.
This profile is AI-generated and may contain inaccuracies.